
FDA orders blindness risk warning on weight loss drugs
Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to add a warning label about a rare eye condition that can cause blindness, the US Food and Drug Administration (FDA) has said.
This story was published by Sky News. Read the full article on their site.
Read the full story at news.sky.com(opens in a new tab)






